PR Newswire | Oct 14, 2021 04:31PM EDT

10/14 15:30 CDT

Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day WASHINGTON, Oct. 14, 2021

WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:

AJ Jones II Chief Corporate Affairs and Communications Officer Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com

Elizabeth Van EveryHead of Corporate Affairs Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com

Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. (202) 734-3400 pr@vandapharma.com

View original content: https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-evercore-isis-catalyst-day-301400804.html

SOURCE Vanda Pharmaceuticals Inc.